A 300-bed acute care hospital in Phoenix faced a dilemma that every healthcare facility manager recognizes: the interior coatings were failing after fifteen years of service, but the facility could not afford the disruption, infection risk, or air quality concerns of a conventional repaint. Peeling paint in patient corridors, stained walls in high-touch zones, and deteriorating lobby finishes were beginning to draw attention during Joint Commission readiness reviews. The facility needed a solution that addressed infection control, low-VOC requirements, and minimal downtime simultaneously.

Phased Execution Timeline

Week 1-2North WingWeek 3-4South WingWeek 5-6OR CorridorsWeek 7-8Lobby & ExteriorICRA Barrier — Negative Air + HEPA FiltrationContinuous containment during all active phasesZero Infections Attributed to Project40% Faster Than Traditional Schedule

Client Challenges

The hospital’s facility director identified five critical constraints that would govern every decision on this project.

First, infection control was non-negotiable. The facility had maintained a below-average healthcare-associated infection rate for three consecutive years, and leadership would not tolerate any construction-related infection event. Any painting activity had to comply with the facility’s Infection Control Risk Assessment (ICRA) protocols and integrate seamlessly with the existing infection prevention program.

Second, patient safety and 24/7 operations meant that no wing could be fully evacuated for painting. The emergency department remained active, surgical schedules continued, and patient rooms turned over daily. Work had to occur in occupied conditions without compromising care delivery or creating navigation hazards for staff, patients, and visitors.

Third, the facility operated under Joint Commission accreditation standards and CMS Conditions of Participation. Any coating failure, visible deterioration, or construction-related citation risk during the upcoming survey cycle had to be eliminated. The project itself could not generate new findings.

Fourth, indoor air quality was a primary concern. Phoenix summers impose heavy cooling loads, and the hospital’s HVAC system was already optimized for energy efficiency. Introducing volatile organic compounds from conventional paints would strain the ventilation system, create odor complaints, and potentially trigger respiratory issues among immunocompromised patients.

Fifth, the timeline was compressed by the upcoming survey window. The facility needed all painting completed, cured, and inspected before the Joint Commission’s announced visit.

Project Scope

The scope encompassed approximately 85,000 square feet of interior surface area across four distinct zones: operating room corridors, patient rooms on two medical-surgical wings, the main lobby and public circulation areas, and select exterior accent walls exposed to intense Arizona UV and thermal cycling.

The OR corridors presented the highest risk profile. These spaces connected six active operating rooms and served as the primary route for sterile case carts, emergency equipment, and surgical staff. Any contamination event in this zone could have immediate patient safety implications.

The patient room wings included 120 rooms across north and south towers, each with private bathrooms, corridors, and nurse stations. These areas required coatings that could withstand aggressive disinfection protocols while contributing to a calming, evidence-based design aesthetic.

The lobby and public areas demanded a premium finish that would withstand heavy visitor traffic, luggage impacts, and frequent cleaning without showing wear. The exterior accent walls required a coating system with proven performance in the Phoenix desert climate, where daily temperature swings of forty degrees and intense solar radiation accelerate coating degradation.

Solution Design

We designed a coating system and execution plan that addressed each constraint through integrated specification and operational controls.

For coatings, we specified a zero-VOC, EPA-registered antimicrobial acrylic system for all interior patient care areas. The base coating contained silver ion technology with documented performance per JIS Z 2801, providing continuous antimicrobial activity between cleaning cycles. A high-performance, low-sheen finish was selected for patient rooms to balance cleanability with glare reduction, while a semi-gloss formulation was used in corridors and high-touch zones for maximum chemical resistance.

For the lobby, we specified a scrubbable, zero-VOC acrylic enamel in a warm neutral palette selected to align with the facility’s evidence-based design goals. The exterior received an elastomeric acrylic coating with UV-resistant pigments and a ten-year substrate warranty, formulated specifically for the thermal expansion and contraction typical of desert-climate masonry.

For infection control, we designed a negative air containment system with HEPA filtration for every active work zone. Each phase was enclosed with sealed plastic sheeting barriers extending from slab to deck, with continuous negative air pressure monitored by magnehelic gauges and logged every two hours. Worker entry and exit routes were segregated from patient circulation paths, with dedicated material staging areas outside the clinical environment.

For scheduling, we developed an eight-week phased plan organized by wing and risk level. The north wing patient rooms were completed first, followed by the south wing, then the OR corridors during a period of lighter elective surgery volume, and finally the lobby and exterior during evening and weekend hours to minimize visitor disruption.

Execution Details

ICRA Barriers and Air Quality Management

Before work began in any zone, the infection prevention team reviewed and signed off on the ICRA plan for that phase. Barriers were constructed with fire-rated plastic sheeting sealed with adhesive-backed tape at all penetrations. Negative air machines with HEPA filtration maintained a minimum of 0.01 inches of water column pressure differential between the work zone and adjacent patient areas.

Air quality was monitored continuously using handheld VOC meters and particulate counters. The zero-VOC coating specification proved critical here: even during active application, VOC levels in adjacent patient corridors remained at or below baseline readings. This eliminated the odor complaints and ventilation adjustments that often accompany conventional painting in healthcare settings.

Daily Terminal Cleaning and Contamination Control

At the conclusion of each work shift, crews performed terminal cleaning of all exposed surfaces within the work zone and a ten-foot buffer area beyond the barrier. This protocol was developed in collaboration with the facility’s environmental services director and matched the hospital’s standard terminal cleaning checklist for discharge rooms.

All tools, ladders, and equipment were cleaned before removal from the work zone. Waste was bagged inside the containment area and removed through designated egress routes that avoided patient care areas. The infection preventionist conducted random audits of barrier integrity and cleaning completion three times per week.

Staff Communication Protocols

Daily huddles at 6:30 a.m. included the project superintendent, the facility’s infection preventionist, the nursing supervisor for the affected wing, and environmental services leadership. A shared digital dashboard provided real-time updates on phase status, barrier locations, and next-day work plans. Nursing staff received text alerts when barrier configurations changed or when temporary egress route modifications were in effect.

A single point of contact from the coating crew was assigned to each wing and carried a radio tuned to the hospital’s internal communication channel. This allowed immediate response to any staff concern, patient complaint, or emergency that required barrier modification or work stoppage.

Progress Tracking and Quality Control

Wet film thickness was verified on every wall coat using calibrated gauges. Dry film thickness was spot-checked at a rate of one measurement per 200 square feet. Adhesion testing was performed on a representative sample of each substrate type using ASTM D3359 cross-hatch methods. All test results were logged in a shared quality control binder available for Joint Commission review.

Results

The project was completed in eight weeks, which was forty percent faster than the facility’s initial timeline estimate based on traditional commercial painting schedules. The acceleration came from the phased approach, which allowed crews to maintain continuous workflow without waiting for full wing evacuations, and from the elimination of weather delays through the zero-VOC specification, which allowed interior work to proceed without extended ventilation periods.

Most importantly, the facility recorded zero healthcare-associated infections attributed to the painting project during the work period or the thirty-day post-completion surveillance window. The infection prevention team attributed this outcome to the rigorous ICRA compliance, the continuous negative air containment, and the daily terminal cleaning protocols.

The project passed the subsequent Joint Commission survey with no environment-of-care citations related to coatings, surfaces, or construction infection control. Surveyors specifically noted the documentation completeness and the visible condition of the newly painted surfaces as supporting evidence of effective facility management.

The coating system carries a ten-year warranty against film failure, chalking, and color shift for the exterior system, and a five-year warranty for the interior antimicrobial system contingent on adherence to the manufacturer’s approved cleaning protocol. The facility’s environmental services team integrated the manufacturer’s cleaning compatibility guidelines into their standard operating procedures, ensuring that the antimicrobial performance will be preserved over the coating lifecycle.

Lessons for Healthcare Facility Managers

This case study demonstrates that healthcare painting projects do not require a choice between infection control, air quality, speed, and durability. The key is integrating specification decisions with operational protocols from the earliest planning stages. Zero-VOC antimicrobial coatings eliminate the indoor air quality barrier that often delays healthcare painting. ICRA-compliant containment and negative air systems protect patients without requiring full wing closures. Phased scheduling by risk level allows continuous operations while maintaining crew productivity.

Facility Manager Checklist

  • Complete ICRA Before Every Phase: Require infection prevention sign-off on barrier design, air pressure differentials, and worker egress routes before work begins in any patient care area.
  • Specify Zero-VOC Antimicrobial Coatings: Use EPA-registered products with documented test data for patient rooms, corridors, and high-touch surfaces to protect air quality and provide residual antimicrobial activity.
  • Verify Chemical Resistance: Confirm that specified coatings withstand your facility’s standard disinfection protocols, including bleach, quaternary ammonium, and hydrogen peroxide-based cleaners.
  • Establish Negative Air Containment: Maintain continuous negative pressure with HEPA filtration in all active work zones, with logged pressure readings every two hours.
  • Coordinate Daily with Infection Prevention: Hold daily huddles with infection prevention, nursing, and environmental services to review barrier status, cleaning completion, and next-day plans.
  • Schedule by Risk Level: Phase work to complete lower-risk areas first, and align high-risk zone work with periods of reduced clinical activity where possible.
  • Document Everything: Maintain product data sheets, safety data sheets, ICRA documentation, air quality logs, and quality control test results for accreditation survey readiness.
  • Integrate Cleaning Protocols: Incorporate manufacturer cleaning compatibility guidelines into environmental services standard operating procedures to preserve antimicrobial performance.